# FDA 483 - The Flex Company - February 03, 2023

Source: https://www.globalkeysolutions.net/records/483/the-flex-company/af8a4462-4306-47ce-b34c-70497fbf2edc

> FDA 483 for The Flex Company on February 03, 2023. Product: device. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: The Flex Company
- Inspection Date: 2023-02-03
- Product Type: device
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: The Flex Company, a medical device manufacturer in Venice, CA, was inspected by the FDA from January 31 to February 3, 2023. The inspection revealed two observations related to inadequate procedures. Specifically, the firm failed to adequately establish procedures for design transfer and for corrective and preventive actions.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/sarah-a-hassas/4f142d54-fc28-4bd5-82ad-7e6fa443688c)

Company: https://www.globalkeysolutions.net/companies/the-flex-company/c36044e8-fe95-4a64-825f-8d8593f6b435

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6